Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Kaminskas

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Drug Development and Industrial Pharmacy|February 16, 2019
Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?Nirmal Marasini, Lisa M Kaminskas
Nanomedicine (London, England)|November 25, 2024
The emergence of inhalable RNA therapeutics and challenges faced - where to from here?Shadabul Haque, Lisa M Kaminskas
Expert Opinion on Drug Delivery|July 23, 2025
Inhaled nanomedicine for lung cancer therapy - will it ever work?Cristina O Esteban, Lisa M Kaminskas
Advanced Drug Delivery Reviews|June 21, 2011
Targeting the lymphatics using dendritic polymers (dendrimers)Lisa M Kaminskas, Christopher J H Porter
Journal of Pharmaceutical Investigation|June 21, 2021
Recent advances in nano/microparticle-based oral vaccinesMengdie Li, Lisa M Kaminskas, Nirmal Marasini
Molecular Pharmacology|August 8, 2012
Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stressPhilip C Burcham, Albert Raso, Lisa M Kaminskas
Rapid Communications in Mass Spectrometry : RCM|February 24, 2007
Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugsLisa M Kaminskas, Simon M Pyke, Philip C Burcham
Current Pharmaceutical Design|December 7, 2018
The Applications of 3D Printing in Pulmonary Drug Delivery and Treatment of Respiratory DisordersShadabul Haque, Shadab Md, Michael Whittaker, et al.
Chemical Research in Toxicology|November 23, 2005
Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytesLisa M Kaminskas, Simon M Pyke, Philip C Burcham
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2004
Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in miceLisa M Kaminskas, Simon M Pyke, Philip C Burcham
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Drug Development and Industrial Pharmacy|February 16, 2019
Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?Nirmal Marasini, Lisa M Kaminskas
Nanomedicine (London, England)|November 25, 2024
The emergence of inhalable RNA therapeutics and challenges faced - where to from here?Shadabul Haque, Lisa M Kaminskas
Expert Opinion on Drug Delivery|July 23, 2025
Inhaled nanomedicine for lung cancer therapy - will it ever work?Cristina O Esteban, Lisa M Kaminskas
Advanced Drug Delivery Reviews|June 21, 2011
Targeting the lymphatics using dendritic polymers (dendrimers)Lisa M Kaminskas, Christopher J H Porter
Journal of Pharmaceutical Investigation|June 21, 2021
Recent advances in nano/microparticle-based oral vaccinesMengdie Li, Lisa M Kaminskas, Nirmal Marasini
Molecular Pharmacology|August 8, 2012
Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stressPhilip C Burcham, Albert Raso, Lisa M Kaminskas
Rapid Communications in Mass Spectrometry : RCM|February 24, 2007
Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugsLisa M Kaminskas, Simon M Pyke, Philip C Burcham
Current Pharmaceutical Design|December 7, 2018
The Applications of 3D Printing in Pulmonary Drug Delivery and Treatment of Respiratory DisordersShadabul Haque, Shadab Md, Michael Whittaker, et al.
Chemical Research in Toxicology|November 23, 2005
Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytesLisa M Kaminskas, Simon M Pyke, Philip C Burcham
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2004
Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in miceLisa M Kaminskas, Simon M Pyke, Philip C Burcham
Pageof 9